We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+2.82%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$231B
AUM Growth
-$701M
Cap. Flow
-$4.96B
Cap. Flow %
-2.15%
Top 10 Hldgs %
13.13%
Holding
8,738
New
866
Increased
3,704
Reduced
3,052
Closed
702

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$514M
2
MDLZ icon
Mondelez International
MDLZ
+$421M
3
COR icon
Cencora
COR
+$225M
4
IVZ icon
Invesco
IVZ
+$212M
5
MON
Monsanto Co
MON
+$205M

Sector Composition

Rank Sector Weight
1 Technology 8.74%
2 Financials 7.28%
3 Healthcare 6.05%
4 Consumer Discretionary 5.36%
5 Energy 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CC icon
2351
Chemours
CC
$2.59B
$4.86M ﹤0.01%
109,458
-43,521
-28% -$2.17M
TRTN
2352
DELISTED
Triton International Limited
TRTN
$4.85M ﹤0.01%
158,304
+66,145
+72% +$2.19M
CRSP icon
2353
CRISPR Therapeutics
CRSP
$4.99B
$4.85M ﹤0.01%
82,525
+23,130
+39% +$1.32M
CIEN icon
2354
Ciena
CIEN
$57.5B
$4.85M ﹤0.01%
182,780
+1,462
+0.8% +$37.1K
RDIV icon
2355
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$1.38B
$4.84M ﹤0.01%
126,524
-115,447
-48% -$4.26M
BWXT icon
2356
BWX Technologies
BWXT
$15.7B
$4.83M ﹤0.01%
77,503
-25,412
-25% -$1.69M
NXQ
2357
DELISTED
NUVEEN ELECT TAX-FREE INC 2
NXQ
$4.82M ﹤0.01%
352,088
+35,449
+11% +$480K
ACGL icon
2358
Arch Capital
ACGL
$34B
$4.8M ﹤0.01%
181,555
-164,780
-48% -$4.43M
SAFM
2359
DELISTED
Sanderson Farms Inc
SAFM
$4.8M ﹤0.01%
45,652
+13,439
+42% +$1.46M
TU icon
2360
Telus
TU
$14.7B
$4.8M ﹤0.01%
270,230
+55,626
+26% +$984K
MCA
2361
DELISTED
BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC
MCA
$4.8M ﹤0.01%
359,641
+106,618
+42% +$1.42M
EWX icon
2362
State Street SPDR S&P Emerging Markets Small Cap ETF
EWX
$679M
$4.8M ﹤0.01%
101,096
+8,444
+9% +$428K
SCCO icon
2363
Southern Copper
SCCO
$162B
$4.8M ﹤0.01%
110,403
+2,630
+2% +$126K
ENZL icon
2364
iShares MSCI New Zealand ETF
ENZL
$83.4M
$4.8M ﹤0.01%
99,195
-925
-0.9% -$45.2K
MTSI icon
2365
MACOM Technology Solutions
MTSI
$20.3B
$4.79M ﹤0.01%
208,081
+143,178
+221% +$3.04M
THQ
2366
abrdn Healthcare Opportunities Fund
THQ
$776M
$4.79M ﹤0.01%
280,976
-40,795
-13% -$684K
ALKS icon
2367
Alkermes
ALKS
$8.29B
$4.77M ﹤0.01%
115,973
-65,952
-36% -$3M
AGZ icon
2368
iShares Agency Bond ETF
AGZ
$564M
$4.77M ﹤0.01%
42,809
-1,262
-3% -$140K
TYL icon
2369
Tyler Technologies
TYL
$12.5B
$4.77M ﹤0.01%
21,473
+1,086
+5% +$244K
ETX
2370
Eaton Vance Municipal Income 2028 Term Trust
ETX
$198M
$4.77M ﹤0.01%
240,943
-43,916
-15% -$849K
XNTK icon
2371
State Street SPDR NYSE Technology ETF
XNTK
$2.19B
$4.76M ﹤0.01%
51,008
-6,872
-12% -$633K
TFX icon
2372
Teleflex
TFX
$6.16B
$4.76M ﹤0.01%
17,748
+5,688
+47% +$1.52M
AX icon
2373
Axos Financial
AX
$5.97B
$4.75M ﹤0.01%
116,110
+24,088
+26% +$1M
JBLU icon
2374
PUT
JetBlue
JBLU
$2.45B
$4.75M ﹤0.01%
250,000
-100,000
-29% -$1.92M
UNG icon
2375
PUT
United States Natural Gas Fund
UNG
$454M
$4.74M ﹤0.01%
50,000
-111,500
-69% -$10.3M

Similar funds

UBS Group's Q2 2018 Portfolio in Review

As of Q2 2018, UBS Group held 8,738 positions worth $231B, down 0.3% from $232B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q2 2018 filing shows 866 new, 3,704 increased, 3,052 reduced and 702 closed positions. Its largest new stake was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M. The largest sale was NXP Semiconductors, an estimated $514M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 8.1% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2018 buy was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $1.01B increase.
  • UBS Group's biggest Q2 2018 reduction was NXP Semiconductors, cutting an estimated $514M.
  • UBS Group fully exited Monsanto Co in Q2 2018, selling an estimated $205M.
  • UBS Group's ten largest holdings make up 13% of its $231B portfolio in Q2 2018.
  • UBS Group opened 866 new positions and closed 702 in Q2 2018.
  • UBS Group's portfolio value fell 0.3% quarter-over-quarter to $231B.

Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.